BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15264681)

  • 21. Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy.
    Nukui A; Masuda A; Abe H; Arai K; Yoshida KI; Kamai T
    BMC Cancer; 2017 May; 17(1):372. PubMed ID: 28545581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum pyridinoline crosslinks as markers of tumour-induced bone resorption.
    Nemoto R; Nakamura I; Nishijima Y; Shiobara K; Shimizu M; Takehara T; Ohta T; Kiyoki M
    Br J Urol; 1997 Aug; 80(2):274-80. PubMed ID: 9284202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma.
    Fedorko M; Stanik M; Iliev R; Redova-Lojova M; Machackova T; Svoboda M; Pacik D; Dolezel J; Slaby O
    Int J Mol Sci; 2015 Sep; 16(10):23382-9. PubMed ID: 26426010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry.
    Hara T; Honda K; Ono M; Naito K; Hirohashi S; Yamada T
    J Urol; 2005 Oct; 174(4 Pt 1):1213-7. PubMed ID: 16145372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum ferritin in renal cell carcinoma: effect of tumor size, volume grade, and stage.
    Singh KJ; Singh SK; Suri A; Vijjan V; Goswami AK; Khullar M
    Indian J Cancer; 2005; 42(4):197-200. PubMed ID: 16391438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.
    Tusong H; Maolakuerban N; Guan J; Rexiati M; Wang WG; Azhati B; Nuerrula Y; Wang YJ
    Cancer Biomark; 2017; 18(1):79-85. PubMed ID: 27814278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated levels of serum aldolase A in patients with renal cell carcinoma.
    Takashi M; Zhu Y; Nakano Y; Miyake K; Kato K
    Urol Res; 1992; 20(4):307-11. PubMed ID: 1509638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum gamma-enolase as a marker for renal cell carcinoma].
    Takashi M; Tanaka J; Mitsuya H; Murase T; Haimoto H; Kato K
    Nihon Hinyokika Gakkai Zasshi; 1988 Feb; 79(2):220-6. PubMed ID: 3225998
    [No Abstract]   [Full Text] [Related]  

  • 29. Expression Levels of PIWI-interacting RNA, piR-823, Are Deregulated in Tumor Tissue, Blood Serum and Urine of Patients with Renal Cell Carcinoma.
    Iliev R; Fedorko M; Machackova T; Mlcochova H; Svoboda M; Pacik D; Dolezel J; Stanik M; Slaby O
    Anticancer Res; 2016 Dec; 36(12):6419-6423. PubMed ID: 27919963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial Comment to Potential tumor markers of renal cell carcinoma: α-enolase for postoperative follow up, and galectin-1 and galectin-3 for primary detection.
    Ornellas AA
    Int J Urol; 2013 May; 20(5):535-6. PubMed ID: 23113761
    [No Abstract]   [Full Text] [Related]  

  • 31. IL-37 mediates the antitumor activity in renal cell carcinoma.
    Jiang Y; Wang Y; Liang L; Gao Y; Chen J; Sun Y; Cheng Y; Xu Y
    Med Oncol; 2015 Nov; 32(11):250. PubMed ID: 26464282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibody against arrestin-1 as a potential biomarker of renal cell carcinoma.
    Baldin AV; Grishina AN; Korolev DO; Kuznetsova EB; Golovastova MO; Kalpinskiy AS; Alekseev BY; Kaprin AD; Zinchenko DV; Savvateeva LV; Varshavsky VA; Zernii EY; Vinarov AZ; Bazhin AV; Philippov PP; Zamyatnin AA
    Biochimie; 2019 Feb; 157():26-37. PubMed ID: 30389514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced cytosolic carboxypeptidase 6 (CCP6) level leads to accumulation of serum polyglutamylated DNAJC7 protein: A potential biomarker for renal cell carcinoma early detection.
    Li C; Wang J; Hao J; Dong B; Li Y; Zhu X; Ding J; Ren S; Zhao H; Wu S; Tian Y; Wang GQ
    Oncotarget; 2016 Apr; 7(16):22385-96. PubMed ID: 26993597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma.
    Ljungberg B; Jacobsen J; Häggström-Rudolfssson S; Rasmuson T; Lindh G; Grankvist K
    Urol Res; 2003 Oct; 31(5):335-40. PubMed ID: 14574539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels.
    Horstmann M; Merseburger AS; von der Heyde E; Serth J; Wegener G; Mengel M; Feil G; Hennenlotter J; Nagele U; Anastasiadis A; Bokemeyer C; Stenzl A; Kuczyk M
    J Cancer Res Clin Oncol; 2005 Nov; 131(11):715-22. PubMed ID: 16080018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum level of ANGPTL4 as a potential biomarker in renal cell carcinoma.
    Dong D; Jia L; Zhou Y; Ren L; Li J; Zhang J
    Urol Oncol; 2017 May; 35(5):279-285. PubMed ID: 28110976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study.
    Bilir C; Yıldız İ; Bilici A; Ucar M; Berk V; Yıldız Y; Yazıcı O; İmamoğlu Gİ; Karadurmuş N; Pilancı KN; Arpacı E; Tanrıverdi Ö; Karcı E; Temiz S; Nayır E; Oktay E; Dal P; Petekkaya İ; Varım C; Cinemre H
    Cancer Invest; 2017 Apr; 35(4):248-255. PubMed ID: 28333566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma.
    Gayed BA; Gillen J; Christie A; Peña-Llopis S; Xie XJ; Yan J; Karam JA; Raj G; Sagalowsky AI; Lotan Y; Margulis V; Brugarolas J
    BMC Urol; 2015 Apr; 15():24. PubMed ID: 25885592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of serum soluble interleukin 2 receptor (sIL-2R) levels in patients with renal cell carcinoma].
    Akiyama K; Tsuji M; Kurokawa Y; Yokota K; Kojima K; Naruo S; Kanayana HO; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1997 Apr; 88(4):473-8. PubMed ID: 9155114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma.
    Jou YC; Tsai YS; Hsieh HY; Chen SY; Tsai HT; Chen KJ; Wang ST; Shiau AL; Wu CL; Tzai TS
    Urol Oncol; 2013 Nov; 31(8):1806-11. PubMed ID: 22609059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.